<DOC>
	<DOCNO>NCT01290484</DOCNO>
	<brief_summary>There unsatisfied medical need first-line treatment lymphatic malformation good benefit/risk profile . Based patient experience institution , investigator plan verify whether medication sildenafil beneficial effect lymphatic malformation . The investigator plan treat patient lymphatic malformation medication sildenafil 20 week period . This investigator initiate study fund Innovations Patient Care grant SPARK grant .</brief_summary>
	<brief_title>A Study Evaluate Sildenafil Treatment Lymphatic Malformations</brief_title>
	<detailed_description>Lymphatic malformation challenge treat . Mainstay intervention include surgery sclerotherapy invasive result local recurrence complication . We seek assess effect 20 week oral sildenafil reduce lymphatic malformation volume symptom child . Seven child ( 4 boy , 3 girl ; age 13-85 month ) lymphatic malformation give oral sildenafil 20 week open-label study . The volume lymphatic malformation calculate blindly use magnetic resonance imaging perform 20 week sildenafil . Lymphatic malformation assess clinically week 4 , 12 , 20 , 32 . Both physician parent evaluate lymphatic malformation comparison baseline . Sildenafil reduce lymphatic malformation volume symptom child . ( J Am Acad Dermatol 2014 ; 70:1050-7 . )</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Lymphangioma</mesh_term>
	<mesh_term>Lymphatic Abnormalities</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>1 . Written informed consent ( ) study participation ( applicable ) use participant 's image obtain accord national regulation participant 's parent ( ) guardian ( ) prior perform study procedure . 2 . The participant 6 month 10 year age inclusion . 3 . The participant weight least 8kg . 4 . A diagnosis LM mix venous lymphatic malformation involve skin subcutaneous tissue least 3cm base clinical radiographic criterion . 5 . LMs may benefit systemic therapy base clinical criterion . 6 . Females must pregnant breastfeeding . 7 . If participant child , parent/guardian must able follow instruction must willing able ensure subject present require study visit . 8 . Subject contraindication use sildenafil . 9 . LMs may involve part body . 10 . Subject normal result screen test ( eye exam , blood test ) . 11 . Subject contraindication MRI examination , metal implant , etc . 12 . Subject must smoker . 1 . The participant medically unstable health status may interfere his/her ability complete study . 2 . The participant present one follow medical condition : hepatic impairment ; severe renal impairment ; lymphedema condition Milroy disease , Meige lymphedema , Hennekam syndrome , Njolstad syndrome , Aagenaes syndrome , Fabry disease ; hypotension risk hypotension ; seizures history seizure ; significant cardiovascular risk factor condition require participant use nitric oxide donor nitrate form ; underlying anatomic vascular risk factor develop nonarteritic anterior ischemic optic neuropathy ( NAION ) include low ocular cup disc ratio , age 10 , diabetes , hypertension , coronary artery disease , hyperlipidemia , smoking . ( Participants Down syndrome , Turner syndrome , Noonan syndrome consider casebycase basis ) . 3 . The participant receive least one follow medication contraindicate association sildenafil within 15 day inclusion : Alprostadil , Azole antifungal , Clarithromycins , Conivaptan , Delavirdine , Erythromycins , Fluvoxamine , Grapefruit , Imatinib , Nefazodone , Nitrates/sodium thiosulfate , Nonselective selective alpha blocker , Protease inhibitor , Rufinamide , Tadalafil , Telithromycin , Vardenafil , Yohimbe , Yohimbine , Amifostine , Lapatinib , Warfarin 4 . The participant require concomitant use potent cytochrome P450 3A4 inhibitor ( ketoconazole , itraconazole , erythromycin , saquinavir ) concomitant use ritonavir . 5 . The patient extensive prior surgery sclerotherapy treat LM scarring may interfere treatment effect sildenafil . 6 . The participant previously administer treatment LMs surgical procedure perform remove index LMs . 7 . Participant currently pregnant consider become pregnant next 20 week . 8 . The participant know allergy sildenafil . 9 . Ulcerated currently infect LMs pain . 10 . Diagnosis soft tissue tumor LM clinically certain . 11 . The participant participate another clinical study . 12 . The participant history priapism diagnose sickle cell anemia disorder may predispose priapism . 13 . The investigator may declare subject ineligible valid medical reason .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Lymphatic malformation , vascular malformation</keyword>
</DOC>